Also known as LX-4211, LX4211
Sotagliflozin, sold under the brand name Inpefa among others, is a medication used to reduce the risk of death due to heart failure. It is an inhibitor of sodium-glucose cotransporter 1 and 2 (SGLT1/SGLT2 inhibitor). It is taken by mouth.
Sotagliflozin, sold under the brand name Inpefa among others, is a medication used to reduce the risk of death due to heart failure. It is an inhibitor of sodium-glucose cotransporter 1 and 2 (SGLT1/SGLT2 inhibitor). It is taken by mouth.
The most common adverse reactions include urinary tract infection, volume depletion, diarrhea, and hypoglycemia.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).